Publication: Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses.
Loading...
Identifiers
Date
2020-07-09
Authors
Seyed Khoei, Nazlisadat
Jenab, Mazda
Murphy, Neil
Banbury, Barbara L
Carreras-Torres, Robert
Viallon, Vivian
Kühn, Tilman
Bueno-de-Mesquita, Bas
Aleksandrova, Krasimira
Cross, Amanda J
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central Ltd.
Abstract
Bilirubin, a byproduct of hemoglobin breakdown and purported anti-oxidant, is thought to be cancer preventive. We conducted complementary serological and Mendelian randomization (MR) analyses to investigate whether alterations in circulating levels of bilirubin are associated with risk of colorectal cancer (CRC). We decided a priori to perform analyses separately in men and women based on suggestive evidence that associations may differ by sex. In a case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC), pre-diagnostic unconjugated bilirubin (UCB, the main component of total bilirubin) concentrations were measured by high-performance liquid chromatography in plasma samples of 1386 CRC cases and their individually matched controls. Additionally, 115 single-nucleotide polymorphisms (SNPs) robustly associated (P The associations between circulating UCB levels and CRC risk differed by sex (Pheterogeneity = 0.008). Among men, higher levels of UCB were positively associated with CRC risk (odds ratio [OR] = 1.19, 95% confidence interval [CI] = 1.04-1.36; per 1-SD increment of log-UCB). In women, an inverse association was observed (OR = 0.86 (0.76-0.97)). In the MR analysis of the main UGT1A1 SNP (rs6431625), genetically predicted higher levels of total bilirubin were associated with a 7% increase in CRC risk in men (OR = 1.07 (1.02-1.12); P = 0.006; per 1-SD increment of total bilirubin), while there was no association in women (OR = 1.01 (0.96-1.06); P = 0.73). Raised bilirubin levels, predicted by instrumental variables excluding rs6431625, were suggestive of an inverse association with CRC in men, but not in women. These differences by sex did not reach formal statistical significance (Pheterogeneity ≥ 0.2). Additional insight into the relationship between circulating bilirubin and CRC is needed in order to conclude on a potential causal role of bilirubin in CRC development.
Description
MeSH Terms
Adult
Aged
Bilirubin
Case-Control Studies
Colorectal Neoplasms
Europe
Female
Humans
Male
Mendelian Randomization Analysis
Middle Aged
Polymorphism, Single Nucleotide
Prospective Studies
Risk Factors
Aged
Bilirubin
Case-Control Studies
Colorectal Neoplasms
Europe
Female
Humans
Male
Mendelian Randomization Analysis
Middle Aged
Polymorphism, Single Nucleotide
Prospective Studies
Risk Factors
DeCS Terms
Análisis de la aleatorización mendeliana
Bilirrubina
Estudios prospectivos
Estudios de casos y controles
Factores de riesgo
Neoplasias colorrectales
Polimorfismo de nucleótido simple
Bilirrubina
Estudios prospectivos
Estudios de casos y controles
Factores de riesgo
Neoplasias colorrectales
Polimorfismo de nucleótido simple
CIE Terms
Keywords
Anti-oxidants, Bilirubin, Cancer, Colorectal cancer, Mendelian randomization analysis
Citation
Seyed Khoei N, Jenab M, Murphy N, Banbury BL, Carreras-Torres R, Viallon V, et al. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses. BMC Med. 2020 Sep 3;18(1):229.